Latest Royalties News

Wide Open Agriculture cut its loss to $3.64 million in FY2026 as it pivots from owning manufacturing to a capital-light contract model, while securing global commercial traction for its lupin-based ingredients.

Kingsgate Consolidated delivered a record FY2026 net profit of $278 million, driven by strong gold and silver output at Chatree and a $68.6 million impairment reversal at the Nueva Esperanza project, while declaring a 10 cent final dividend.

Ceretas Limited posted a $1.63 million net loss for FY26 on $1.28 million revenue from government grants, advancing its clinical-stage Alzheimer’s ultrasound platform. The company completed an $8 million IPO in July to fund pivotal trials and device development.

Perpetual Resources has digitised and reviewed 42 historical drill holes from its Nevada Scheelite tungsten project, identifying 22 with significant tungsten grades, underpinning plans for modern validation and 3D geological modelling.

PT ANTAM (ASX:ATM) posted a 6% increase in net sales to Rp62.71 trillion in the first half of 2026, driven by steady gold, nickel, and bauxite sales. Profit after tax surged 34% to Rp6.91 trillion, supported by improved margins and foreign exchange gains.

Castile Resources reveals a robust 2026 Scoping Study for its Rover 1 IOCG Project, projecting an 11-year underground mine life with five valuable metals driving strong economics and a staged development strategy.

Cambium Bio has secured FDA agreement on a streamlined single pivotal Phase 3 trial for Elate Ocular®, cutting development costs and timelines. Despite a AUD 4.1 million loss for FY2026, the company strengthened its funding position and manufacturing partnerships ahead of patient dosing targeted for late 2026.

Austral Resources Australia Ltd has swung from a $24.2 million loss to a $25.3 million profit in the first half of 2026, boosted by strategic acquisitions, capital raises, and operational shifts. The company is advancing its Rocklands restart and has proposed acquiring Hammer Metals to expand its copper footprint.

Weebit Nano surged to record revenue of $15.3 million in FY26, fueled by key licensing deals and product tape-outs, while investing heavily in R&D and AI initiatives. Despite a $54.9 million loss, a $102 million capital raise leaves the company well-positioned for growth.

Zimplats Holdings reported a strong FY2026 with revenue climbing 57% to US$1.3 billion and profit before tax soaring 484% to US$387.5 million, driven by higher metal prices, increased ore volumes, and improved operational efficiency.

Elevra Lithium posted a $44 million profit in FY26 after merging Sayona Mining and Piedmont Lithium, overcoming temporary mining challenges and securing full funding for the North American Lithium expansion.

Argent BioPharma has secured a key FDA regulatory milestone with the establishment of an Investigational New Animal Drug (INAD) file for its CannEpil veterinary program, targeting cancer-related pain in companion animals.